1. Academic Validation
  2. Fusobacterium nucleatum promotes bladder cancer progression and immune escape by activating the IL22/STAT3/PD-L1 signaling cascade

Fusobacterium nucleatum promotes bladder cancer progression and immune escape by activating the IL22/STAT3/PD-L1 signaling cascade

  • Tissue Cell. 2025 Jul 29:97:103065. doi: 10.1016/j.tice.2025.103065.
Yunjie Yang 1 Yang Chen 2 Qi Liu 3 Lixian Guan 2 Gengqi Liang 2
Affiliations

Affiliations

  • 1 Department of Pediatric Surgery, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, No. 120, Guidan Road, Nanhai District, Foshan City, Guangdong Province 528200, PR China. Electronic address: ey_61011@163.com.
  • 2 Department of Urinary Surgery, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, No. 120, Guidan Road, Nanhai District, Foshan City, Guangdong Province 528200, PR China.
  • 3 Department of Gastroenterology, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, No. 120, Guidan Road, Nanhai District, Foshan City, Guangdong Province 528200, PR China.
Abstract

Objective: This study investigates the mechanism by which Fusobacterium nucleatum (Fn) promotes bladder Cancer (BC) progression and immune escape through the interleukin 22 (IL22)/signal transducer and activator of transcription 3 (STAT3)/programmed death-ligand 1 (PD-L1) cascade signaling.

Methods: Fecal samples from BC patients (n = 73) and healthy controls (n = 39) were analyzed for Fn abundance using qRT-PCR. IL-22, p-STAT3, STAT3, and PD-L1 levels were determined by qRT-PCR and western blot. The in vitro cultured human BC cell line (T24) were co-cultured with Fn, followed by CCK-8, colony formation, and Transwell assays to assess cell viability, proliferation, and invasion and migration, respectively. A co-culture system of T24 and CD8-positive T lymphocytes (CD8+ T) cells was established. Immune responses were assessed by determining tumor necrosis factor alpha (TNF-α), interferon gamma (INF-γ), granzyme B (GZMB), and pore-forming protein (Perforin) levels in supernatants. In vivo studies using a BC mouse model examined tumor progression and immune markers through flow cytometry, focusing on CD8+ T cells and regulatory T cell (Treg) populations. Immunohistochemical assay was conducted to measure ki67 levels in tumor tissues.

Results: Fn levels were significantly elevated in BC patients' feces. Fn treatment enhanced Cancer cell viability, proliferation, invasion, and migration. Fn activated the IL22/STAT3/PD-L1 pathway and showed positive correlations with these markers in BC tissues. In the co-culture system, Fn reduced CD8+ T cell function and increased Treg proportions in tumor tissues. The in vivo experiments confirmed that Fn promoted IL22/STAT3/PD-L1 expression, altered immune cell ratios, and increased ki67 expression levels.

Conclusion: Fn promotes the IL22/STAT3/PD-L1 cascade signaling, thereby facilitating in vivo progression and immune evasion of BC.

Keywords

Bladder cancer; Fusobacterium nucleatum; Immune evasion; Interleukin 22; Programmed death-ligand 1; Signal transducer and activator of transcription.

Figures
Products